# A Phase IV Randomized Trial of Maxigesic® Versus Standard Analgesia After Radical Gastrectomy

> **NCT07687394** · PHASE4 · NOT_YET_RECRUITING · sponsor: **Yonsei University** · enrollment: 160 (estimated)

## Conditions studied

- Stomach Neoplasms
- Pain
- Postoperative

## Interventions

- **DRUG:** Acetaminophen (Newaminophen Premix)
- **DRUG:** Maxigesic IV (acetaminophen/ibuprofen)

## Key facts

- **NCT ID:** NCT07687394
- **Lead sponsor:** Yonsei University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-01
- **Primary completion:** 2028-10-01
- **Final completion:** 2028-12-31
- **Target enrollment:** 160 (ESTIMATED)
- **Last updated:** 2026-07-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07687394

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07687394, "A Phase IV Randomized Trial of Maxigesic® Versus Standard Analgesia After Radical Gastrectomy". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07687394. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*